minoxidil and latanoprost

minoxidil has been researched along with latanoprost in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
El-Ashmawy, AA; El-Maadawy, IH; El-Maghraby, GM1
Bergfeld, W; Murad, A1
Cantelli, M; Fabbrocini, G; Napolitano, M; Nappa, P; Patruno, C; Vastarella, M1
Cunha-Filho, M; França, LCF; Gelfuso, GM; Gratieri, T; Oliveira, PM; Sampaio, TR1
Alencar-Silva, T; Carvalho, JL; Cunha-Filho, M; Gelfuso, GM; Gratieri, T; Oliveira, PM; Pires, FQ1
Behrangi, E; Ghassemi, M; Goodarzi, A; Jafari, M; Yazdanian, N1

Reviews

1 review(s) available for minoxidil and latanoprost

ArticleYear
Treatment for facial alopecia areata: A systematic review with evidence-based analysis.
    Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:3

    Topics: 11-beta-Hydroxysteroid Dehydrogenases; Alopecia Areata; Anthralin; Bimatoprost; Cyclopropanes; Dermatologic Agents; Drug Therapy, Combination; Eyebrows; Eyelashes; Facial Dermatoses; Humans; Latanoprost; Minoxidil; Photosensitizing Agents; Prostaglandins F, Synthetic

2018

Trials

2 trial(s) available for minoxidil and latanoprost

ArticleYear
Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata.
    The Journal of dermatological treatment, 2018, Volume: 29, Issue:1

    Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia Areata; Betamethasone Valerate; Child; Child, Preschool; Female; Humans; Latanoprost; Male; Middle Aged; Minoxidil; Prostaglandins F, Synthetic; Recurrence; Single-Blind Method; Treatment Outcome; Young Adult

2018
Comparison of efficacy, safety and satisfaction of latanoprost versus minoxidil, betamethasone and in combination in patients with alopecia areata: A blinded multiple group randomized controlled trial.
    Dermatologic therapy, 2022, Volume: 35, Issue:12

    Topics: Administration, Topical; Adult; Alopecia; Alopecia Areata; Betamethasone; Double-Blind Method; Female; Humans; Latanoprost; Male; Minoxidil; Ophthalmic Solutions; Patient Satisfaction; Personal Satisfaction; Treatment Outcome; Young Adult

2022

Other Studies

5 other study(ies) available for minoxidil and latanoprost

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Allergic contact dermatitis probably caused by latanoprost during treatment for alopecia areata.
    Contact dermatitis, 2019, Volume: 81, Issue:1

    Topics: Administration, Cutaneous; Alopecia Areata; Dermatitis, Allergic Contact; Facial Dermatoses; Female; Humans; Latanoprost; Middle Aged; Minoxidil; Patch Tests; Scalp Dermatoses

2019
LC-MS bioanalytical method for simultaneous determination of latanoprost and minoxidil in the skin.
    Journal of pharmaceutical and biomedical analysis, 2020, Aug-05, Volume: 187

    Topics: Administration, Cutaneous; Animals; Calibration; Chromatography, Liquid; Latanoprost; Limit of Detection; Mass Spectrometry; Minoxidil; Reproducibility of Results; Skin; Swine

2020
Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2022, Volume: 172

    Topics: Administration, Topical; Alopecia; Animals; Drug Delivery Systems; Hair Follicle; Humans; Latanoprost; Minoxidil; Swine

2022